FDA commissioner stirs debate over hormone therapy for menopause

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat menopause.   

The 12-person panel encouraged the use of the treatment late last week and called for the removal of the Food and Drug Administration’s “black box” warning label on hormone treatments.   

“I am begging the FDA, and all of us are begging, please remove the black box label,” said  JoAnn Pinkerton, a panelist and professor of obstetrics and gynecology...